EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Neurochemical organization of cortical proteinopathy and neurophysiology along the Alzheimer's disease continuum

Alex I Wiesman iD, Jonathan Gallego-Rudolf, Sylvia Villeneuve, Sylvain Baillet, Tony W Wilson, PREVENT‐AD Research Group

Alzheimer's & Dementia · 2024-09 · 20 (9) · 6316-6331

DOI: 10.1002/alz.14110 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 12.07.2024. Verfasst von Alex I Wiesman und 5 weiteren Autor:innen. Beteiligte Einrichtung: McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada. Hauptthemen laut MEDLINE: Alzheimer Disease, Magnetoencephalography, Positron-Emission Tomography, Amyloid beta-Peptides. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Alzheimer Society of Canada, Healthy Brains Healthy Lives program at McGill University, Canada Research Chairs.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Despite parallel research indicating amyloid‐β accumulation, alterations in cortical neurophysiological signaling, and multi‐system neurotransmitter disruptions in Alzheimer's disease (AD), the relationships between these phenomena remains unclear. METHODS Using magnetoencephalography, positron emission tomography, and an atlas of 19 neurotransmitters, we studied the alignment between neurophysiological alterations, amyloid‐β deposition, and the neurochemical gradients of the cortex. RESULTS In patients with mild cognitive impairment and AD, changes in cortical rhythms were topographically aligned with cholinergic, serotonergic, and dopaminergic systems. These alignments correlated with the severity of clinical impairments. Additionally, cortical amyloid‐β plaques were preferentially deposited along neurochemical boundaries, influencing how neurophysiological alterations align with muscarinic acetylcholine receptors. Most of the amyloid‐β‐neurochemical and alpha‐band neuro‐physio‐chemical alignments replicated in an independent dataset of individuals with asymptomatic amyloid‐β accumulation. DISCUSSION Our findings demonstrate that AD pathology aligns topographically with the cortical distribution of chemical neuromodulator systems and scales with clinical severity, with implications for potential pharmacotherapeutic pathways. Highlights Changes in cortical rhythms in Alzheimer's are organized along neurochemical boundaries. The strength of these alignments is related to clinical symptom severity. Deposition of amyloid‐β (Aβ) is aligned with similar neurotransmitter systems. Aβ deposition mediates the alignment of beta rhythms with cholinergic systems. Most alignments replicate in participants with pre‐clinical Alzheimer's pathology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseMagnetoencephalographyPositron-Emission TomographyAmyloid beta-PeptidesCerebral CortexHumansAgedMaleFemaleCognitive DysfunctionNeurotransmitter AgentsAged, 80 and overPlaque, Amyloid

Stichwörter der Autor:innen

Alzheimer's disease continuumamyloid‐βmagnetoencephalographymild cognitive impairmentneural oscillationsneurotransmitter systemsrhythmic neurophysiological signalingspectral parameterization

Substanzen

Amyloid beta-PeptidesNeurotransmitter Agents

Autor:innen und Institutionen

  • McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada.
  • Department of Biomedical Physiology & Kinesiology, Simon Fraser University, Burnaby, British Columbia, Canada.
  • Douglas Mental Health University Institute, Montreal, Quebec, Canada.
  • Institute for Human Neuroscience, Boys Town National Research Hospital, Omaha, Nebraska, USA.
  • Department of Pharmacology & Neuroscience, Creighton University, Omaha, Nebraska, USA.

ORCID-Profile: Alex I Wiesman

Förderung

  • Alzheimer Society of Canada
  • Healthy Brains Healthy Lives program at McGill University
  • Canada Research Chairs
  • NINDS NIH HHS
  • United States National Institutes of Health
  • Natural Sciences and Engineering Research Council of Canada
  • Brain Canada
  • Alzheimer Association

Zitieren

APA

Wiesman, A. I., Gallego-Rudolf, J., Villeneuve, S., Baillet, S., Wilson, T. W., & PREVENT‐AD Research Group (2024). Neurochemical organization of cortical proteinopathy and neurophysiology along the Alzheimer's disease continuum. Alzheimer's & Dementia, 20(9), 6316-6331. https://doi.org/10.1002/alz.14110

Vancouver

Wiesman AI, Gallego-Rudolf J, Villeneuve S, Baillet S, Wilson TW, PREVENT‐AD Research Group. Neurochemical organization of cortical proteinopathy and neurophysiology along the Alzheimer's disease continuum. Alzheimer's & Dementia. 2024;20(9):6316-6331. doi:10.1002/alz.14110

BibTeX
@article{Wiesman2024,
  author = {Wiesman, Alex I and Gallego-Rudolf, Jonathan and Villeneuve, Sylvia and Baillet, Sylvain and Wilson, Tony W and PREVENT‐AD Research Group, PREVENT‐AD Research Group},
  title = {Neurochemical organization of cortical proteinopathy and neurophysiology along the Alzheimer's disease continuum},
  journal = {Alzheimer's & Dementia},
  year = {2024},
  volume = {20},
  number = {9},
  pages = {6316--6331},
  doi = {10.1002/alz.14110}
}
Kostenlos starten →